Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer

BackgroundNon–small cell lung cancer (NSCLC) has entered the era of immunotherapy. However, only partial patients were able to benefit from immune checkpoint inhibitors (ICIs). Currently, biomarkers for predicting patients’ response to ICIs are primarily tumor tissue dependent and have limited accur...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Kang Miao, Xiaotong Zhang, Hanping Wang, Xiaoyan Si, Jun Ni, Wei Zhong, Jing Zhao, Yan Xu, Minjiang Chen, Ruili Pan, Mengzhao Wang, Li Zhang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2022-07-01
Edice:	Frontiers in Immunology
Témata:	immune checkpoint inhibitors (ICIs) lymphocyte subsets CD4+CD45RA− T cell biomarker CD8+CD38+ T cell
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.912180/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!